GE Healthcare exhibited the Lunar Prodigy Primo, a bone mineral density (BMD) system designed to help doctors detect and diagnose osteoporosis, a preventative bone-loss disease that affects one out of two women and one in eight men over the age of 50. The Prodigy Primo was showcased at the 55th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG) in San Diego this week.
The Primo system is built on the industry standard Lunar Prodigy, a method for bone density testing and detecting low bone mass and increased risk of fracture. The Primo offers the same Prodigy series direct digital technology, precision and accuracy, but in a redesigned package to meet the needs of the primary care and in-office physician.
“With the Primo, we can now take BMD to the point of care allowing a broader spectrum of clinicians to help detect BMD issues earlier, diagnose more precisely and make better treatment decisions,” said Jennie Hanson, president of GE Healthcare’s Lunar business.
At the heart of the Primo is the revolutionary enCORExpress 6-Click user-interface and OneScan easy operation technique. These applications provide easy operation for beginners enabling clinicians to: perform a BMD exam in six clicks, from measurement to final results. The enCORExpress seamless user-interface is icon-driven with limited choices allowing for a more streamlined decision-making process; and GE’s OneScan operation technique helps clinicians to perform a BMD exam in a few clicks, from measurement to final results.
According to the National Osteoporosis Foundation, Osteoporosis is a major public health threat for almost 44 million US women and men aged 50 and older. By the year 2010, it is estimated that over 52 million women and men in this same age category will be affected and, if current trends continue, the figure will climb to over 61 million by 2020. According to a U.S. Surgeon General’s Report, approximately 1.5 million bone fractures per year are attributable to osteoporosis and healthcare expenditures related to osteoporosis are estimated to be $18 billion per year.